fig2

TGF-β stimulation of EMT programs elicits non-genomic ER-α activity and anti-estrogen resistance in breast cancer cells

Figure 2. Induction of EMT programs by TGF-β promotes ER-α accumulation in the cytoplasm of MCF-7 cells. (A) MCF-7 cells were treated with either TGF-β1 (5 ng/mL), estradiol (1 nmol/L), or both agonists for 96 h as indicated. Afterward, the cells were fixed in paraformaldehyde and processed for indirect E-cad immunofluorescence. Images are representative of 3-independent experiments (×400). (B and C) MCF-7 cells were treated with TGF-β1 (5 ng/mL) in either 2D- (B) or 3D- (C) cultures for 0-96 h, at which point differences in ER-α expression were measured by real-time PCR. Data are the mean fold-changes (± SE; n = 3; *P < 0.05; Student's t-test). (D) Differential mRNA expression of ER-α and ER-β in quiescent MCF-7 cells. Data are the mean (± SE; n = 3; *P < 0.05; Student's t-test). (E) MCF-7 (top) and BT474 (bottom) cells were stimulated with TGF-β1 (5 ng/mL) for 0-96 h. Afterward, ER-α expression levels were monitored by immunoblotting. Images are representative of 4-independent experiments. (F) MCF-7 cells were transiently transfected overnight with either the pSBE- or pERE-luciferase reporter genes, as well as with the pCMV-β-galactosidase reporter gene to control for differences in transfection efficiency. Afterward, the transfectants were stimulated overnight either singly or in combination with TGF-β1 (T; 5 ng/mL) or estradiol (E; 0.1 nmol/L) prior to measuring luciferase and β-gal activities. Data are the mean fold-changes (± SE; n = 3; *P < 0.05; Student's t-test). (G) Pre- and post-EMT MCF-7 cells were transiently transfected overnight with pERE-luciferase and pCMV-β-gal-luciferase cDNAs, followed by 24 h treatment with either TGF-β1 (5 ng/mL) or estradiol (0.1 nmol/L). Data are the mean fold-changes (± SE; n = 3; *P < 0.05; Student's t-test). (H) MCF-7 cells were treated with TGF-β1 (5 ng/mL) for 0-96 h, at which point the expression of ER-α in cytoplasmic and nuclear cell fractions was determined by immunoblotting. Stripped blots were reprobed with antibodies to either HDAC1 or β-actin to monitor integrity of nuclear and cytoplasmic fractions, respectively. Images are representative of at least 3-independent experiments. TGF: transforming growth factor; EMT: epithelial-mesenchymal transition; ER: estrogen receptor; SE: standard error

Journal of Cancer Metastasis and Treatment
ISSN 2454-2857 (Online) 2394-4722 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/